genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Big Data
From the Bench to Benchling
Drug Discovery
Astellas Takes AIRM Opening New Regenerative Medicine Institute in Massachusetts
Gene Therapy
The Italian Job: An Interview with Gene Therapist Federico Mingozzi
Coronavirus
A ‘Patch’-Work Solution to Vaccine Delivery
Bioinformatics
NVIDIA Powers Up in Drug Discovery
News
Coronavirus
HIV Glycans: Shield Shifters and Spike Stabilizers
Cancer
AI Reportedly Matches Tumors to Best Drug Combinations
Coronavirus
Gilead’s Remdesivir Wins FDA’s First COVID-19 Drug Approval
Cancer
Solving the MCM Paradox and What It Means for Cancer
Autism
Maternal Use of Antiepileptic Drug Linked with Increased Risk of Neurodevelopmental…
Insights
All
Trends for 2020
Bioprocessing
Digital Pharma Is a Major Cultural Change
Bioprocessing
Contract Manufacturer Sets Up for Fill-and-Finish Next-Generation Therapies
Gene Therapy
The Italian Job: An Interview with Gene Therapist Federico Mingozzi
Bioprocessing
Ori Biotech Raises $30 Million in Financing
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Coronavirus
HIV Glycans: Shield Shifters and Spike Stabilizers
Cancer
AI Reportedly Matches Tumors to Best Drug Combinations
Coronavirus
Gilead’s Remdesivir Wins FDA’s First COVID-19 Drug Approval
Cancer
Solving the MCM Paradox and What It Means for Cancer
Magazine
October 2020 Vol. 40 No. 10
Spatial: The Next Omics Frontier
October 2020 Vol. 40 No. 10
Gene Therapy Startups Extend Biotech’s Legacy
October 2020 Vol. 40 No. 10
Viral or Nonviral: Which Is Better for CRISPR-Based Therapies?
October 2020 Vol. 40 No. 10
The Chronicles of CRISPR
October 2020 Vol. 40 No. 10
Host Cell Protein Analysis Informs Risk Assessment
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Viral Vectors
Viral Vectors
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Viral Vectors
Scalable Plasmid-Free AAV Manufacturing
Viral Vectors
MilliporeSigma Launches VirusExpress Lentiviral Production Platform
Viral Vectors
J&J’s Janssen Pauses COVID-19 Vaccine Trials, Including 60,000-Patient Phase III Study
Point of View
A CDMO’s Perspective on AAV Vector Production
Viral Vectors
Redefining AAV Manufacturing: The Time Is Now
Viral Vectors
J&J’s Janssen Launches Up-to-60,000-Patient Phase III Trial for COVID-19 Vaccine
Viral Vectors
COVID-19: AstraZeneca, U. of Oxford Resume Phase III Trial; Pfizer, BioNTech...
Viral Vectors
AstraZeneca Pauses Phase III COVID-19 Vaccine Trial, Citing “Potentially Unexplained Illness”
Viral Vectors
AstraZeneca Launches 30,000-Patient Phase III U.S. Trial of COVID-19 Vaccine
GEN Live
Gene Therapy: What’s Up With AAV?
Viral Vectors
Quartet of COVID-19 Vaccine Candidates Head toward the Homestretch
Viral Vectors
AstraZeneca, U. of Oxford Report Positive Phase I/II Data for COVID-19...
Viral Vectors
Tiny Cas Protein, Huge Gene Editing Potential … Thanks, Megaphage!
Viral Vectors
Gene Therapy: It’s Time to Talk about High-Dose AAV
Viral Vectors
Moving Forward after Two Deaths in a Gene Therapy Trial of...
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
